When terminating therapy, taper day-to-day dosage by much less than or equal to 0.1 mg every 3 to 7 days.
No studies reviewing abrupt discontinuation of clonidine hydrochloride extended-release tablets in youngsters with ADHD have been carried out.
In adults with high blood pressure, unexpected cessation of clonidine hydrochloride extended-release solution therapy in the 0.2 to 0.6 mg/day variety resulted in reports of frustration, tachycardia, queasiness, flushing, warm sensation, brief lightheadedness, tightness in upper body, and also anxiety.